Mitochondrial Electron Transport Chain Complex Dysfunction in MeCP2 Knock-Down Astrocytes: Protective Effects of Quercetin Hydrate

[1]  J. Langhnoja,et al.  Correction to: Role of astrocytic MeCP2 in regulation of CNS myelination by affecting oligodendrocyte and neuronal physiology and axo–glial interactions , 2018, Experimental Brain Research.

[2]  J. Langhnoja,et al.  Correction to: Role of astrocytic MeCP2 in regulation of CNS myelination by affecting oligodendrocyte and neuronal physiology and axo–glial interactions , 2018, Experimental Brain Research.

[3]  Buch Lipi,et al.  Role of astrocytic MeCP2 in regulation of CNS myelination by affecting oligodendrocyte and neuronal physiology and axo–glial interactions , 2018, Experimental Brain Research.

[4]  Li-Nan Qiu,et al.  Quercetin attenuates mitochondrial dysfunction and biogenesis via upregulated AMPK/SIRT1 signaling pathway in OA rats. , 2018, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[5]  E. Levy,et al.  Apple peel polyphenols reduce mitochondrial dysfunction in mice with DSS-induced ulcerative colitis. , 2018, The Journal of nutritional biochemistry.

[6]  E. Lacivita,et al.  Stimulation of the brain serotonin receptor 7 rescues mitochondrial dysfunction in female mice from two models of Rett syndrome , 2017, Neuropharmacology.

[7]  A. Tripathi,et al.  Differential Regulation of MeCP2 Phosphorylation by Laminin in Oligodendrocytes , 2017, Journal of Molecular Neuroscience.

[8]  L. Mills,et al.  Mitochondrial Dysfunction in the Pathogenesis of Rett Syndrome: Implications for Mitochondria-Targeted Therapies , 2017, Front. Cell. Neurosci..

[9]  C. Cervellati,et al.  Proteomic analysis of 4-hydroxynonenal and nitrotyrosine modified proteins in RTT fibroblasts. , 2016, The international journal of biochemistry & cell biology.

[10]  N. Shulyakova.  Studies of Mitochondrial Dysfunction in Models of Rett Syndrome , 2016 .

[11]  L. Costa,et al.  Mechanisms of Neuroprotection by Quercetin: Counteracting Oxidative Stress and More , 2016, Oxidative medicine and cellular longevity.

[12]  R. Cacabelos,et al.  Epigenetics of Aging and Alzheimer’s Disease: Implications for Pharmacogenomics and Drug Response , 2015, International journal of molecular sciences.

[13]  A. Dinkova-Kostova,et al.  The emerging role of Nrf2 in mitochondrial function , 2015, Free radical biology & medicine.

[14]  H. Forman,et al.  Impaired enzymatic defensive activity, mitochondrial dysfunction and proteasome activation are involved in RTT cell oxidative damage. , 2015, Biochimica et biophysica acta.

[15]  E. Frost,et al.  Involvement of MeCP2 in Regulation of Myelin-Related Gene Expression in Cultured Rat Oligodendrocytes , 2015, Journal of Molecular Neuroscience.

[16]  C. Fiorentini,et al.  Mitochondrial free radical overproduction due to respiratory chain impairment in the brain of a mouse model of Rett syndrome: protective effect of CNF1. , 2015, Free radical biology & medicine.

[17]  G. Cortopassi,et al.  Dysregulation of Glutamine Transporter SNAT1 in Rett Syndrome Microglia: A Mechanism for Mitochondrial Dysfunction and Neurotoxicity , 2015, The Journal of Neuroscience.

[18]  G. Valacchi,et al.  Redox Imbalance and Morphological Changes in Skin Fibroblasts in Typical Rett Syndrome , 2014, Oxidative medicine and cellular longevity.

[19]  M. D'Esposito,et al.  Oxidative brain damage in Mecp2-mutant murine models of Rett syndrome , 2014, Neurobiology of Disease.

[20]  P. Tam,et al.  Mitochondrial dysfunction in skeletal muscle of a mouse model of Rett Syndrome ( RTT ) : Implications for the disease phenotype . , 2014 .

[21]  Michaela K. Müller,et al.  The free radical scavenger Trolox dampens neuronal hyperexcitability, reinstates synaptic plasticity, and improves hypoxia tolerance in a mouse model of Rett syndrome , 2014, Front. Cell. Neurosci..

[22]  G. Valacchi,et al.  Genes Related to Mitochondrial Functions, Protein Degradation, and Chromatin Folding Are Differentially Expressed in Lymphomonocytes of Rett Syndrome Patients , 2013, Mediators of inflammation.

[23]  G. Mandel,et al.  Oligodendrocyte Lineage Cells Contribute Unique Features to Rett Syndrome Neuropathology , 2013, The Journal of Neuroscience.

[24]  David A. Orlando,et al.  Global transcriptional and translational repression in human-embryonic-stem-cell-derived Rett syndrome neurons. , 2013, Cell stem cell.

[25]  R. Sandhir,et al.  Quercetin supplementation is effective in improving mitochondrial dysfunctions induced by 3-nitropropionic acid: implications in Huntington's disease. , 2013, Biochimica et biophysica acta.

[26]  Huichun Xu,et al.  MeCP2 modulates gene expression pathways in astrocytes , 2013, Molecular Autism.

[27]  L. Opitz,et al.  Oxidative burden and mitochondrial dysfunction in a mouse model of Rett syndrome , 2012, Neurobiology of Disease.

[28]  V. Pertegato,et al.  Assessment of mitochondrial respiratory chain enzymatic activities on tissues and cultured cells , 2012, Nature Protocols.

[29]  Vladimir Parpura,et al.  Calcium signalling in astroglia , 2012, Molecular and Cellular Endocrinology.

[30]  G. Valacchi,et al.  Morphological changes and oxidative damage in Rett Syndrome erythrocytes. , 2012, Biochimica et biophysica acta.

[31]  S. T. Choudhury,et al.  The use of nano-quercetin to arrest mitochondrial damage and MMP-9 upregulation during prevention of gastric inflammation induced by ethanol in rat. , 2012, Biomaterials.

[32]  M. D'Esposito,et al.  Partial rescue of Rett syndrome by ω-3 polyunsaturated fatty acids (PUFAs) oil , 2012, Genes & Nutrition.

[33]  Catalina Carrasco-Pozo,et al.  Differential protective effects of quercetin, resveratrol, rutin and epigallocatechin gallate against mitochondrial dysfunction induced by indomethacin in Caco-2 cells. , 2012, Chemico-biological interactions.

[34]  James C. Cronk,et al.  Wild type microglia arrest pathology in a mouse model of Rett syndrome , 2012, Nature.

[35]  L. Goya,et al.  Quercetin modulates Nrf2 and glutathione-related defenses in HepG2 cells: Involvement of p38. , 2012, Chemico-biological interactions.

[36]  J. Raber,et al.  A role for glia in the progression of Rett’s syndrome , 2011, Nature.

[37]  G. Valacchi,et al.  Oxidative stress in Rett syndrome: Natural history, genotype, and variants , 2011, Redox report : communications in free radical research.

[38]  Y. Sasaguri,et al.  Quercetin induces the expression of peroxiredoxins 3 and 5 via the Nrf2/NRF1 transcription pathway. , 2011, Investigative ophthalmology & visual science.

[39]  S. Perry,et al.  Mitochondrial membrane potential probes and the proton gradient: a practical usage guide. , 2011, BioTechniques.

[40]  P. Vora,et al.  A novel transcriptional regulator of myelin gene expression: implications for neurodevelopmental disorders , 2010, Neuroreport.

[41]  K. Manaye,et al.  Anti-depressant natural flavonols modulate BDNF and beta amyloid in neurons and hippocampus of double TgAD mice , 2010, Neuropharmacology.

[42]  Izumi Maezawa,et al.  Rett Syndrome Microglia Damage Dendrites and Synapses by the Elevated Release of Glutamate , 2010, The Journal of Neuroscience.

[43]  J. Christodoulou,et al.  Downstream targets of methyl CpG binding protein 2 and their abnormal expression in the frontal cortex of the human Rett syndrome brain , 2010, BMC Neuroscience.

[44]  Guy A Rutter,et al.  Mitochondrial calcium as a key regulator of mitochondrial ATP production in mammalian cells. , 2009, Biochimica et biophysica acta.

[45]  G. Valacchi,et al.  Systemic oxidative stress in classic Rett syndrome. , 2009, Free radical biology & medicine.

[46]  M. Marino,et al.  Quercetin-induced apoptotic cascade in cancer cells: antioxidant versus estrogen receptor alpha-dependent mechanisms. , 2009, Molecular nutrition & food research.

[47]  S. Kügler,et al.  Remodelling of the respiratory network in a mouse model of Rett syndrome depends on brain‐derived neurotrophic factor regulated slow calcium buffering , 2009, The Journal of physiology.

[48]  D. Harvey,et al.  Rett Syndrome Astrocytes Are Abnormal and Spread MeCP2 Deficiency through Gap Junctions , 2009, The Journal of Neuroscience.

[49]  G. Mandel,et al.  Non–cell autonomous influence of MeCP2-deficient glia on neuronal dendritic morphology , 2009, Nature Neuroscience.

[50]  R. Scarpulla,et al.  Nuclear Control of Respiratory Chain Expression by Nuclear Respiratory Factors and PGC‐1‐Related Coactivator , 2008, Annals of the New York Academy of Sciences.

[51]  D. Clapham,et al.  Calcium Signaling , 2007, Cell.

[52]  Jie Peng,et al.  Isolation and culture of rat and mouse oligodendrocyte precursor cells , 2007, Nature Protocols.

[53]  A. Bird,et al.  Gene Expression Analysis Exposes Mitochondrial Abnormalities in a Mouse Model of Rett Syndrome , 2006, Molecular and Cellular Biology.

[54]  A. Leslie,et al.  How azide inhibits ATP hydrolysis by the F-ATPases. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[55]  D. Nicholls.  Simultaneous Monitoring of Ionophore- and Inhibitor-mediated Plasma and Mitochondrial Membrane Potential Changes in Cultured Neurons* , 2006, Journal of Biological Chemistry.

[56]  Qun Chen,et al.  Depletion of cardiolipin and cytochrome c during ischemia increases hydrogen peroxide production from the electron transport chain. , 2006, Free radical biology & medicine.

[57]  R. Scarpulla,et al.  Nuclear control of respiratory gene expression in mammalian cells , 2006, Journal of cellular biochemistry.

[58]  S. Confort-Gouny,et al.  Brain magnetic resonance study of Mecp2 deletion effects on anatomy and metabolism. , 2006, Biochemical and biophysical research communications.

[59]  D. Nicholls.  Mitochondria and calcium signaling. , 2005, Cell calcium.

[60]  P. Brookes,et al.  Calcium, ATP, and ROS: a mitochondrial love-hate triangle. , 2004, American journal of physiology. Cell physiology.

[61]  C. Rice-Evans,et al.  Flavonoids: antioxidants or signalling molecules? , 2004, Free radical biology & medicine.

[62]  A. Baracca,et al.  Rhodamine 123 as a probe of mitochondrial membrane potential: evaluation of proton flux through F(0) during ATP synthesis. , 2003, Biochimica et biophysica acta.

[63]  Sheng-Nan Wu,et al.  Differential effects of quercetin, a natural polyphenolic flavonoid, on L‐Type calcium current in pituitary tumor (GH3) cells and neuronal NG108‐15 cells , 2003, Journal of cellular physiology.

[64]  Thomas D. Schmittgen,et al.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.

[65]  R. Artuch,et al.  Oxidative stress in Rett syndrome , 2001, Brain and Development.

[66]  H. Zoghbi,et al.  Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2 , 1999, Nature Genetics.

[67]  J. Joseph,et al.  Quantifying cellular oxidative stress by dichlorofluorescein assay using microplate reader. , 1999, Free radical biology & medicine.

[68]  A. Federico,et al.  Vitamin E serum levels in Rett syndrome , 1998, Journal of the Neurological Sciences.

[69]  D. Clapham,et al.  Calcium signaling , 1995, Cell.

[70]  A. Bird,et al.  Purification, sequence, and cellular localization of a novel chromosomal protein that binds to Methylated DNA , 1992, Cell.

[71]  Peng Liu,et al.  Quercetin ameliorates hypobaric hypoxia-induced memory impairment through mitochondrial and neuron function adaptation via the PGC-1α pathway. , 2015, Restorative neurology and neuroscience.

[72]  Thomas D. Schmittgen,et al.  Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2 2 DD C T Method , 2022 .